Testing effectiveness (Phase 2)Ended earlyNCT05464836
What this trial is testing
Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL
Who this might be right for
Leukemia, LymphoblasticLeukemia
M.D. Anderson Cancer Center 2